(0.05%) 5 472.24 points
(0.07%) 39 140 points
(0.37%) 17 783 points
(-0.05%) $80.79
(-3.66%) $2.66
(-0.79%) $2 312.50
(0.25%) $28.94
(3.61%) $1 022.00
(0.29%) $0.936
(0.69%) $10.68
(0.46%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease...
Stats | |
---|---|
今日成交量 | 156 199 |
平均成交量 | 481 622 |
市值 | 424.27M |
EPS | $-0.200 ( Q1 | 2024-05-13 ) |
下一个收益日期 | ( $-0.380 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-45.88 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0190 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-05 | Vitale Nancy | Buy | 24 000 | Stock Option (Right to Buy) |
2024-06-05 | Scangos George A | Buy | 24 000 | Stock Option (Right to Buy) |
2024-06-05 | Pierce Glenn | Buy | 24 000 | Stock Option (Right to Buy) |
2024-06-05 | Onyia Jude | Buy | 24 000 | Stock Option (Right to Buy) |
2024-06-05 | Mackey Catherine J | Buy | 24 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
49.70 |
Last 94 transactions |
Buy: 7 197 476 | Sell: 3 598 715 |
音量 相关性
Voyager Therapeutics Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Voyager Therapeutics Inc 相关性 - 货币/商品
Voyager Therapeutics Inc 财务报表
Annual | 2023 |
营收: | $250.01M |
毛利润: | $245.57M (98.22 %) |
EPS: | $3.08 |
FY | 2023 |
营收: | $250.01M |
毛利润: | $245.57M (98.22 %) |
EPS: | $3.08 |
FY | 2022 |
营收: | $40.91M |
毛利润: | $34.72M (84.87 %) |
EPS: | $-1.210 |
FY | 2021 |
营收: | $37.42M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.890 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Voyager Therapeutics Inc
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。